Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

23
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
23
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

32
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
32
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

1.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.8K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

31
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
31
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

1.5K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.5K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

37
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
37

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Contractility Drives Cardiomyocyte Maturation and the Response to Nanopatterns.

Circulation research·2026
Same author

A next-generation human lymphatic filariasis vaccine candidate, rBmHAXT, for clinical development.

NPJ vaccines·2026
Same author

The E525K β-Myosin Mutation Causes Hypocontractility in Cardiomyocytes Without Altering Loaded Crossbridge Cycling.

bioRxiv : the preprint server for biology·2026
Same author

Impact of a standardized documentation template on hospital case mix index and reimbursement for patients with traumatic brain and spine injuries.

Journal of neurosurgery·2026
Same author

Capturing the dynamics of STAT6 macrophage polarization using bioluminescence temporal signatures.

Cell systems·2026
Same author

When stigma hits home: A mixed methods study of affiliate stigma among epilepsy care partners.

Epilepsy & behavior : E&B·2026

Related Experiment Video

Updated: Aug 29, 2025

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

10.1K

Antigen presentation by cardiac fibroblasts promotes cardiac dysfunction.

Njabulo Ngwenyama1, Kuljeet Kaur1, Darrian Bugg2

  • 1Department of Immunology, Tufts University, Boston, MA, USA.

Nature Cardiovascular Research
|September 12, 2022
PubMed
Summary

Cardiac fibroblasts act as antigen-presenting cells (APCs) in heart failure, modulating immune responses. This discovery reveals a new mechanism contributing to cardiac fibrosis and dysfunction in heart failure.

More Related Videos

Isolation and Characterization of Adult Cardiac Fibroblasts and Myofibroblasts
10:45

Isolation and Characterization of Adult Cardiac Fibroblasts and Myofibroblasts

Published on: March 12, 2020

16.2K
Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
09:16

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Published on: June 3, 2018

7.4K

Related Experiment Videos

Last Updated: Aug 29, 2025

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

10.1K
Isolation and Characterization of Adult Cardiac Fibroblasts and Myofibroblasts
10:45

Isolation and Characterization of Adult Cardiac Fibroblasts and Myofibroblasts

Published on: March 12, 2020

16.2K
Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
09:16

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Published on: June 3, 2018

7.4K

Area of Science:

  • Immunology
  • Cardiology
  • Fibrosis Research

Background:

  • Heart failure (HF) involves CD4+ T cells and cardiac fibroblasts, with known crosstalk leading to fibrosis.
  • The role of cardiac fibroblasts in modulating T cell responses during HF pathogenesis remains unclear.

Purpose of the Study:

  • To investigate whether cardiac fibroblasts influence pathogenic cardiac CD4+ T cell immune responses.
  • To determine if cardiac fibroblasts act as antigen-presenting cells (APCs) in cardiac inflammation.

Main Methods:

  • Murine models of cardiac inflammation and pressure overload.
  • Assessment of major histocompatibility complex type II (MHCII) expression on cardiac fibroblasts.
  • Analysis of antigen uptake and presentation by cardiac fibroblasts to CD4+ T cells.
  • Conditional deletion of MHCII in cardiac fibroblasts to evaluate functional impact.

Main Results:

  • Murine cardiac fibroblasts express MHCII during cardiac inflammation.
  • Cardiac fibroblasts process antigens and present them to CD4+ T cells via IFNγ-induced MHCII.
  • Conditional deletion of MHCII in cardiac fibroblasts improved cardiac remodeling and function under pressure overload.

Conclusions:

  • Cardiac fibroblasts function as antigen-presenting cells (APCs) in the context of cardiac inflammation.
  • IFNγ-induced MHCII expression enables cardiac fibroblasts to modulate CD4+ T cell responses.
  • Cardiac fibroblasts contribute to HF-associated fibrosis and dysfunction by presenting antigens via MHCII.